Weight loss of 5% or greater was achieved by 79.2% of patients on semaglutide 25mg vs 31.1% of those on placebo (P <.0001). Semaglutide-treated patients also saw significant improvements in ...

About a third of semaglutide users achieved both inflammation reduction and scarring improvement, more than double compared to those taking the placebo. The drug also helped participants with weight ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

The semaglutide group achieved a weight loss of 10.5% at 72 weeks compared with 2% for adults receiving placebo (estimated difference, –8.5 percentage points; 95% CI, –9.6 to –7.4 ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...

How Long Does It Take for Semaglutide to Work? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide is the active ingredient in the weight loss medication Wegovy and the ...

The cutting-edge weight-loss drug ... taking semaglutide stopped their fatty liver disease without further scarring of the organ -- 63%, compared with 34% of those taking a placebo, researchers ...

versus 22.4% in the placebo group. Participants treated with semaglutide also saw improvements in liver enzymes and blood measures of liver fibrosis, as well as 10.5% weight loss. Some adverse ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.